Immunai
- Managed infrastructure and managed operations of cross-functional laboratory R&D, software and computational teams in production and processing of multi-omic single cell sequencing data from clinical samples, which increased efficiency in data generation and transfer- Carried out healthcare data management from the single cell processing pipeline (Freezerworks, LIMS, Benchling), which streamlined data processing in time, work effort and resources- Managed projects with external commercial (big pharma) and academic collaborators (SOW, product development process, timelines, deliverables, IP, reports) as PoC of company capabilities providing novel biological insights in healthcare data
0
0
0
Key Info
- 2019 Founded
- 300.50M Total Funding Raised
- New York, New York, USA
- 155 Employees
- •••••••••
Team
Investments
There is no investment data on this organization.